Build status - In Progress
LIFE Study: Entresto TM in Advanced Heart Failure
Recruiting
18 years - 100 years
All
Phase
3
20 participants needed
1 Location
Brief description of study
This study aims to understand the benefits/risks of Entresto in NYHA III-IV patients.
Detailed description of study
Follow up visits include taking study drug (Entresto vs Valsartan), blood work, physical exam, questionnaires, 6 min walk tests, and medication review.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Entresto,heart failure,end stage,blood pressure,heart disease,ejection fraction,cardiology,heart
-
Age: 18 years - 100 years
-
Gender: All
Updated on
04 Aug 2024.
Study ID: 825912
Find a site
,
Your Information has been sent successfully.
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or